Zhongfu Zuo

663 total citations
44 papers, 477 citations indexed

About

Zhongfu Zuo is a scholar working on Molecular Biology, Pharmacology and Physiology. According to data from OpenAlex, Zhongfu Zuo has authored 44 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 7 papers in Pharmacology and 7 papers in Physiology. Recurrent topics in Zhongfu Zuo's work include Medicinal Plants and Bioactive Compounds (7 papers), Retinal Diseases and Treatments (6 papers) and Molecular Sensors and Ion Detection (4 papers). Zhongfu Zuo is often cited by papers focused on Medicinal Plants and Bioactive Compounds (7 papers), Retinal Diseases and Treatments (6 papers) and Molecular Sensors and Ion Detection (4 papers). Zhongfu Zuo collaborates with scholars based in China and South Korea. Zhongfu Zuo's co-authors include Xuezheng Liu, Aihua Liu, Qiang Zhang, Lihua Liu, Wenqiang Liu, Yang Hou, Lihua Wang, Yanmei Ma, Zhansheng Hu and Xiaoyu Zhang and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Zhongfu Zuo

41 papers receiving 467 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhongfu Zuo China 12 225 68 61 53 52 44 477
Yaqi Zhou China 15 294 1.3× 107 1.6× 46 0.8× 55 1.0× 63 1.2× 44 651
Jürgen Fingerle Switzerland 18 238 1.1× 78 1.1× 41 0.7× 68 1.3× 62 1.2× 26 724
Jiankang Fang Macao 11 243 1.1× 44 0.6× 26 0.4× 73 1.4× 18 0.3× 16 484
Mohamed El‐Shafey Egypt 16 176 0.8× 29 0.4× 25 0.4× 50 0.9× 35 0.7× 27 495
Kevin Edgar United Kingdom 13 212 0.9× 46 0.7× 48 0.8× 85 1.6× 49 0.9× 25 489
Khader Awwad Germany 11 185 0.8× 50 0.7× 24 0.4× 82 1.5× 18 0.3× 20 417
Vinchi Wang Taiwan 12 196 0.9× 30 0.4× 26 0.4× 31 0.6× 23 0.4× 31 436
Jorgelina M. Calandria United States 12 247 1.1× 40 0.6× 82 1.3× 51 1.0× 15 0.3× 18 509
Zekiye Altun Türkiye 16 202 0.9× 72 1.1× 17 0.3× 43 0.8× 58 1.1× 79 625
Chi-Hao Tsai Taiwan 10 163 0.7× 57 0.8× 47 0.8× 16 0.3× 21 0.4× 16 375

Countries citing papers authored by Zhongfu Zuo

Since Specialization
Citations

This map shows the geographic impact of Zhongfu Zuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhongfu Zuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhongfu Zuo more than expected).

Fields of papers citing papers by Zhongfu Zuo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhongfu Zuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhongfu Zuo. The network helps show where Zhongfu Zuo may publish in the future.

Co-authorship network of co-authors of Zhongfu Zuo

This figure shows the co-authorship network connecting the top 25 collaborators of Zhongfu Zuo. A scholar is included among the top collaborators of Zhongfu Zuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhongfu Zuo. Zhongfu Zuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Xinyue, Jianhong Liu, Haowen Zhou, et al.. (2025). A lysosome-targeted fluorescent probe for ratiometric imaging of in vitro and in vivo. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 347. 127012–127012.
2.
Niu, Lin, Min Xu, Wenqiang Liu, et al.. (2024). The GLCCI1/STAT3 pathway: a novel pathway involved in diabetic cognitive dysfunction and the therapeutic effect of salidroside. Journal of Molecular Histology. 55(5). 851–861. 1 indexed citations
3.
4.
Li, Na, Min Xu, Ji‐Lin Chen, et al.. (2024). Salidroside protects RGC from pyroptosis in diabetes-induced retinopathy associated with NLRP3, NFEZL2 and NGKB1, revealed by network pharmacology analysis and experimental validation. European journal of medical research. 29(1). 60–60. 6 indexed citations
5.
Li, Na, Ji‐Lin Chen, Min Xu, et al.. (2024). Molecular network mechanism in cerebral ischemia-reperfusion rats treated with human urine stem cells. Heliyon. 10(7). e27508–e27508. 1 indexed citations
6.
7.
Na, Li, Min Xu, Ji‐Lin Chen, et al.. (2023). 4D-DIA quantitative proteomics revealed the core mechanism of diabetic retinopathy after berberine treatment. European Journal of Pharmacology. 958. 175947–175947. 10 indexed citations
8.
Liu, Wenqiang, Yufei Wang, Cong Fu, et al.. (2023). Relationship between IL-22 and IL-22BP in diabetic cognitive dysfunction. Acta Diabetologica. 60(5). 631–644. 2 indexed citations
9.
Yu, Hongdan, Jing Li, Wenqiang Liu, et al.. (2022). Th22 cells induce Müller cell activation via the Act1/TRAF6 pathway in diabetic retinopathy. Cell and Tissue Research. 390(3). 367–383. 4 indexed citations
10.
Liang, Jia, Pan Wang, Pan Wang, et al.. (2021). β-1, 3-galactosyltransferase 2 ameliorates focal ischemic cerebral injury by maintaining blood-brain barrier integrity. Neurochemistry International. 144. 104976–104976. 9 indexed citations
11.
Zhang, Tianyi, Wenqiang Liu, Wei Hou, et al.. (2021). Increased PYCR1 mRNA predicts poor prognosis in kidney adenocarcinoma. Medicine. 100(38). e27145–e27145. 6 indexed citations
12.
Xu, Kai, Wenqiang Liu, Anqi Liu, et al.. (2021). Protective Effect of Raf-1 Kinase Inhibitory Protein on Diabetic Retinal Neurodegeneration through P38-MAPK Pathway. Current Eye Research. 47(1). 135–142. 9 indexed citations
13.
Wang, Peng, Xibin Zhou, Yu Shao, et al.. (2021). CdS quantum dots-decorated InOOH: Facile synthesis and excellent photocatalytic activity under visible light. Journal of Colloid and Interface Science. 601. 186–195. 15 indexed citations
14.
Wang, Qiulin, et al.. (2020). Construction of the gene network in the spinal cord injury treated by coptidis rhizoma based on network pharmacological and molecular docking. SHILAP Revista de lepidopterología. 6(3). 24–33. 1 indexed citations
15.
Dong, Jun, et al.. (2019). Berberine ameliorates diabetic neuropathic pain in a rat model: involvement of oxidative stress, inflammation, and μ-opioid receptors. Naunyn-Schmiedeberg s Archives of Pharmacology. 392(9). 1141–1149. 30 indexed citations
16.
Yan, Wei, Zheng He, Jun Dong, et al.. (2019). MicroRNA-30b is involved in the pathological process of diabetes mellitus induced by pancreatic cancer by regulating plasminogen activator inhibitor-1. Biotechnology & Biotechnological Equipment. 33(1). 1741–1749. 2 indexed citations
17.
Jin, Meihua, Pengfei Lv, Guanyu Chen, et al.. (2017). Klotho ameliorates cyclosporine A–induced nephropathy via PDLIM2/NF-kB p65 signaling pathway. Biochemical and Biophysical Research Communications. 486(2). 451–457. 35 indexed citations
18.
Zhang, Lan, Xuezheng Liu, Zhongfu Zuo, Chunyan Hao, & Yanmei Ma. (2016). Sphingosine kinase 2 promotes colorectal cancer cell proliferation and invasion by enhancing MYC expression. Tumor Biology. 37(6). 8455–8460. 24 indexed citations
19.
Zuo, Zhongfu, Yonghui Liao, Tan Ding, et al.. (2015). Astrocytic NDRG2 is involved in glucocorticoid-mediated diabetic mechanical allodynia. Diabetes Research and Clinical Practice. 108(1). 128–136. 8 indexed citations
20.
Liu, Xuezheng, et al.. (2014). Upregulation of Nogo receptor expression induces apoptosis of retinal ganglion cells in diabetic rats. Neural Regeneration Research. 9(8). 815–815. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yaqi Zhou Breakdown of academic impact, for papers by Jürgen Fingerle Breakdown of academic impact, for papers by Jiankang Fang Breakdown of academic impact, for papers by Mohamed El‐Shafey Breakdown of academic impact, for papers by Kevin Edgar Breakdown of academic impact, for papers by Khader Awwad Breakdown of academic impact, for papers by Vinchi Wang Breakdown of academic impact, for papers by Jorgelina M. Calandria Breakdown of academic impact, for papers by Zekiye Altun Breakdown of academic impact, for papers by Chi-Hao Tsai
Rankless by CCL
2026